News

Filter

Current filters:

Merck KGaA

1 to 9 of 4776 results

Merck Serono and Sysmex Inostics open first liquid biopsy RAS biomarker testing center

Merck Serono and Sysmex Inostics open first liquid biopsy RAS biomarker testing center

20-02-2015

Merck Serono, the biopharmaceutical business of Germany’s Merck KGaA, announced today that the first…

Merck KGaAMerck SeronoOncologyPharmaceuticalResearchSpainSysmex Inostics

Merck transfers diabetes and thyroid business from Takeda to its own operations in Russia

Merck transfers diabetes and thyroid business from Takeda to its own operations in Russia

02-02-2015

Germany’s Merck KGaA has transferred responsibility for its diabetes and thyroid portfolio from marketing…

DiabetesMarkets & MarketingMerck KGaAMerck SeronoPharmaceuticalProductionRussia

Moderate growth forecast for colorectal cancer drug market

22-01-2015

The value of the colorectal cancer (CRC) therapeutics market will increase moderately, from $8.3 billion…

AvastinBayerBristol-Myers SquibbErbituxGlobalMarkets & MarketingMerck KGaAOncologyPharmaceuticalRocheStivarga

Merck enters lucrative cancer alliance with Pfizer

Merck enters lucrative cancer alliance with Pfizer

17-11-2014

Germany’s Merck KGaA said today that it has entered into a global agreement with US pharma giant Pfizer…

BiotechnologyGermanyLicensingMarkets & MarketingMerck KGaAMerck SeronoMSB0010718COncologyPfizerUSAXalkori

Merck KGaA raises forecasts on solid third-quarter 2014

Merck KGaA raises forecasts on solid third-quarter 2014

13-11-2014

German pharma and chemicals firm Merck KGaA this morning reported that revenue for the third quarter…

FinancialGermanyMerck KGaAMerck SeronoPharmaceutical

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

07-10-2014

German life sciences major Merck KGaA says its biopharma division Merck Serono has entered into a co-development…

BiotechnologyGermanyLicensingMerck KGaAMerck SeronoOncologyResearch

Merck KGaA in $11 billion deal for Sigma-Aldrich

Merck KGaA in $11 billion deal for Sigma-Aldrich

22-09-2014

Germany’s life sciences group Merck KGaA has entered into a definitive agreement to acquire USA-based…

GermanyMerck KGaAMergers & AcquisitionsMilliporePharmaceuticalSigma-Aldrich

Merck KGaA promotes pharma CEO Stefan Oschmann to deputy CEO

Merck KGaA promotes pharma CEO Stefan Oschmann to deputy CEO

18-09-2014

The board of partners of Germany’s Merck KGaA has promoted Stefan Oschmann to the position of deputy…

BoardroomGermanyMerck KGaAPharmaceuticalStefan Oschmann

1 to 9 of 4776 results

Back to top